Related Experiment Video
Updated: Sep 3, 2025

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma
Published on: January 5, 2017
Involvement of the Substance P/Neurokinin-1 Receptor System in Cancer
Rafael Coveñas1,2, Miguel Muñoz3,4
1Laboratory of Neuroanatomy of the Peptidergic Systems, Institute of Neurosciences of Castilla and León (INCYL), University of Salamanca, 37007 Salamanca, Spain.
Abstract:
New, promising molecular targets to block tumor development and new compounds capable of specifically destroying cancer cells must be urgently investigated [...].
Insights
Urgent investigation into novel molecular targets and compounds is crucial for blocking tumor progression and destroying cancer cells. This research focuses on identifying new strategies for effective cancer therapy.
Area of Science:
- Oncology
- Molecular Biology
- Drug Discovery
Background:
- Tumor development requires identification of novel molecular targets.
- Development of specific compounds for cancer cell destruction is essential.
- Urgent investigation is needed to advance cancer treatment strategies.
Discussion:
- Exploring new molecular targets can inhibit tumor growth.
- Developing targeted compounds offers a promising approach for cancer therapy.
- The study emphasizes the need for innovative solutions in oncology.
Key Insights:
- Identification of promising molecular targets for cancer therapy.
- Discovery of novel compounds with cancer-destroying capabilities.
- Highlighting the critical need for research in cancer treatment.
Outlook:
- Future research should focus on validating these molecular targets.
- Further development of identified compounds is necessary for clinical application.
- This work paves the way for next-generation cancer therapies.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Cancer Cell Migration through Invadopodia
Mitogens and the Cell Cycle
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

